http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20050021629-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36d7a121242a4f897fa144f9f988dd99 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate | 2003-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05d88c82158d225c222bfcb2c6ada382 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e0c26dc9ae3085322e655fe040457ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed03f95edaa99db781e20c9fa735e08f |
| publicationDate | 2005-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20050021629-A |
| titleOfInvention | Novel benzofluorene dione derivatives |
| abstract | The present invention relates to a compound represented by the following formula (1), a pharmaceutically acceptable salt thereof, a preparation method thereof and a pharmaceutical composition thereof. Since the compound effectively inhibits cell proliferation, the compound may be used as a prophylactic, therapeutic and therapeutic aid for various cancers.n n n [Formula 1]n n n n n n n n In the above formula, the definition of ring A and ring B is as defined in the specification of the present invention. |
| priorityDate | 2003-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 137.